ESC 365 - Geranylgeranylacetone as prevention for postoperative Atrial Fibrillation (GENIALITY trial)

ESC2025 Premium Access

Geranylgeranylacetone as prevention for postoperative Atrial Fibrillation (GENIALITY trial)

Session: Prediction of atrial fibrillation recurrences: still a challenge

Topic: Prevention

Speaker: Doctor K. Silva Ramos (Amsterdam, NL)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Kennedy Silva Ramos

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

0 follower

6 more presentations in this session

How does artificial intelligence-derived electrocardiographic age and sex predict recurrence outcomes after atrial fibrillation catheter ablation?

Speaker: Doctor H. Park (Seoul, KR)

The role of pulmonary vein anatomy in predicting atrial arrhythmia recurrence after pulsed-field ablation

Speaker: Mr M. Mutti (Basel, CH)

The impact of atrial fibrillation progression on the epicardial adipose tissue volume: supporting 'AF begets EAT' theory

Speaker: Doctor K. Shimojo (Ogaki, JP)

Common genetic variants associated with characteristics and clinical outcomes of atrial fibrillation: from a large population based registry (FinnGen)

Speaker: Doctor A. Maan (Toledo, US)

Impact of low hemoglobin levels on arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation

Speaker: Doctor Y. Matsunaga (Sakai, JP)

Access the full session

Prediction of atrial fibrillation recurrences: still a challenge

Speakers: Doctor K. Silva Ramos, Doctor H. Park, Mr M. Mutti, Doctor K. Shimojo, Doctor A. Maan...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources